122 related articles for article (PubMed ID: 17580551)
21. The natural history of osteoporosis.
Ballard PA; Purdie DW
Br J Hosp Med; 1996 Apr 17-30; 55(8):503-7. PubMed ID: 8732224
[TBL] [Abstract][Full Text] [Related]
22. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
Rasheed A; Khurshid R; Aftab L
J Ayub Med Coll Abbottabad; 2008; 20(1):48-51. PubMed ID: 19024185
[TBL] [Abstract][Full Text] [Related]
23. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
[TBL] [Abstract][Full Text] [Related]
24. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
25. Low bone mineral density and fracture burden in postmenopausal women.
Cranney A; Jamal SA; Tsang JF; Josse RG; Leslie WD
CMAJ; 2007 Sep; 177(6):575-80. PubMed ID: 17846439
[TBL] [Abstract][Full Text] [Related]
26. Evaluation and treatment of bone disease after fragility fracture.
Gibson MV
Geriatrics; 2008 Jul; 63(7):21-30. PubMed ID: 18593210
[TBL] [Abstract][Full Text] [Related]
27. The role of physical activity in the prevention of osteoporosis in postmenopausal women-An update.
Schmitt NM; Schmitt J; Dören M
Maturitas; 2009 May; 63(1):34-8. PubMed ID: 19356867
[TBL] [Abstract][Full Text] [Related]
28. [Pathophysiology and genetics of osteoporosis].
Cohen-Solal M; Marie P; De Vernejoul MC
Ann Med Interne (Paris); 2000 Sep; 151(5):373-9. PubMed ID: 11033471
[No Abstract] [Full Text] [Related]
29. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
30. Incidence of fragility fractures.
Tarantino U; Cannata G; Lecce D; Celi M; Cerocchi I; Iundusi R
Aging Clin Exp Res; 2007 Aug; 19(4 Suppl):7-11. PubMed ID: 18182886
[TBL] [Abstract][Full Text] [Related]
31. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
[TBL] [Abstract][Full Text] [Related]
32. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
Rosa J; Vanuga P; Payer J; Svobodník A
Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
[TBL] [Abstract][Full Text] [Related]
33. Treatment strategies for patients with low bone mass: the younger postmenopausal female.
Honig S
Bull NYU Hosp Jt Dis; 2008; 66(3):240-3. PubMed ID: 18937639
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
35. Women with low-energy fracture should be investigated for osteoporosis.
Löfman O; Hallberg I; Berglund K; Wahlström O; Kartous L; Rosenqvist AM; Larsson L; Toss G
Acta Orthop; 2007 Dec; 78(6):813-21. PubMed ID: 18236189
[TBL] [Abstract][Full Text] [Related]
36. Association between low lean body mass and osteoporotic fractures after menopause.
Capozza RF; Cure-Cure C; Cointry GR; Meta M; Cure P; Rittweger J; Ferretti JL
Menopause; 2008; 15(5):905-13. PubMed ID: 18520697
[TBL] [Abstract][Full Text] [Related]
37. The relationship of calcium intake and exercise to osteoporosis health beliefs in postmenopausal women.
Swaim RA; Barner JC; Brown CM
Res Social Adm Pharm; 2008 Jun; 4(2):153-63. PubMed ID: 18555968
[TBL] [Abstract][Full Text] [Related]
38. Evaluating bone health in women with oestrogen receptor positive breast cancer (ERBC) starting aromatase inhibitors.
Clunie GP; Clark A; Mortimer CJ; Stephenson S; Aitken J; Smith C; Sherwin E; Archer TJ
Eur J Surg Oncol; 2009 May; 35(5):475-80. PubMed ID: 18950981
[TBL] [Abstract][Full Text] [Related]
39. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
40. Knowledge and compliance from patients with postmenopausal osteoporosis treatment.
Palacios S; Sánchez-Borrego R; Neyro JL; Quereda F; Vázquez F; Pérez M; Pérez M
Menopause Int; 2009 Sep; 15(3):113-9. PubMed ID: 19723681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
